US Supreme Court Seems Convinced Purdue Bankruptcy Plan Should Go Forward
Justices acknowledged that the release of the Sackler family from civil liability is a boon for them but appeared averse to rejecting a plan that is supported by the vast majority of victims of the opioid crisis.
You may also be interested in...
The advocates say the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) and its Substance Abuse Treatment Center Programs Combined Survey has conflicts of interest, as well as a connection to the infamous maker of OxyContin.
Purdue pleads guilty to three felony charges over marketing of OxyContin under settlement that requires Purdue to be dissolved and transformed into an entity that provides addiction and overdose medicines. Twenty-five state AGs oppose creation of a PBC, arguing Purdue should be sold to another company.
Filing stays litigation but state attorneys general will be battling company's settlement proposal in US bankruptcy court. Details emerge on Purdue finances, rebate expenditures and litigation costs.